Cambridge Antibody Technology : Director Share Transaction

Director Share Transaction

CATCo Reinsurance Opportunities Fund Ltd. ("the Company")

Director Share Transaction

To: SFM, London Stock Exchange and Bermuda Stock Exchange

Date: 2 March 2016

The Company was notified on 1 March 2016 that Margaret Gadow, non-executive director of the Company, purchased 13,048 Ordinary Shares of US$0.0001 in the Company (representing 0.005% of the Company's issued Ordinary Shares) on 1 March 2016 through the London Stock Exchange at a price of US$1.23 per share. Following this transaction, Margaret Gadow's total interest in the ordinary issued share capital of the Company is 55,901 Ordinary Shares (representing 0.02% of the Company's issued Ordinary Shares).

The ISIN for the Ordinary Shares in the Company is BMG1961Q2095.

For further information:

Judith Wynne

Company Secretary and General Counsel Markel CATCo Investment Management Ltd. Telephone: [phone]

Email: [e-mail]

Mark Way

Chief Operating Officer

Markel CATCo Investment Management Ltd. Telephone: [phone]

Email: [e-mail]

David Benda / Hugh Jonathan Numis Securities Limited Telephone: [phone]